
CURE Finance offers a smart online banking and financial management platform for doctors and dentists. The CURE Praxismanager provides real-time analysis of practice finances, categorizing income and expenses to offer clear insights into liquidity and tax matters. It aims to improve practice profitability by identifying savings potentials and providing AI-driven recommendations. The platform also offers features like liquidity forecasting, automated reporting, and the ability to delegate financial tasks to team members. Security is emphasized with bank-level standards and German server locations certified under ISO 27001:2013. CURE Finance operates on a SaaS model with 'Professionell' and 'Premium' tiers, catering to the specific needs of medical practices.

CURE Finance offers a smart online banking and financial management platform for doctors and dentists. The CURE Praxismanager provides real-time analysis of practice finances, categorizing income and expenses to offer clear insights into liquidity and tax matters. It aims to improve practice profitability by identifying savings potentials and providing AI-driven recommendations. The platform also offers features like liquidity forecasting, automated reporting, and the ability to delegate financial tasks to team members. Security is emphasized with bank-level standards and German server locations certified under ISO 27001:2013. CURE Finance operates on a SaaS model with 'Professionell' and 'Premium' tiers, catering to the specific needs of medical practices.
Sector: Fintech for medical practices
Headquarters: Berlin, Germany
Core product: CURE Praxismanager — open-finance multibanking practice-management platform
Target users: Independent physicians and dental practices
Funding: Seed round (Oct 11, 2021); total reported ~$1.62M
Financial management, bookkeeping automation and cash-flow forecasting for medical practices.
2023
Fintech
Crunchbase records a Seed round on this date and lists three investors including Redstone.VC and Ilavska Vuillermoz Capital.
“Rebmann Research holds a majority stake (strategic partnership announced Feb 22, 2024)”